Gene is the Founder and Executive Chairman of the board of directors and the visionary behind the Avellino Labs network of companies. A serial entrepreneur, he started Avellino Labs in 2008 in South Korea and brings more than 30 years of experience leading pharmaceutical, healthcare, and genetic diagnostics teams. In 2011, Gene relocated to Silicon Valley to support Avellino Labs’ transition to a US-based global company. In 2015, the World Economic Forum recognized Avellino Labs as a Technology Pioneer and honored Gene with membership on its Global Precision Medicine Council. Gene is also the Founder and Chairman of AIOnco, a company developing proprietary applications of data and artificial intelligence for the advancement of cancer detection. He is the lead inventor and author of most of the patents in Avellino and AIOnco’s respective IP portfolio. In 2019, Gene was awarded the prestigious Ellis Island Medal of Honor in recognition of his pioneering work in gene therapy and molecular diagnostics.